Crossmark

Performance of risk models in predicting outcomes of atezolizumab and bevacizumab therapy

Crossref DOI link: https://doi.org/10.1007/s00535-026-02355-y

Published Online: 2026-02-05

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hatanaka, Takeshi https://orcid.org/0000-0003-3656-285X
Kakizaki, Satoru

Naganuma, Atsushi

Hiraoka, Atsushi

Tada, Toshifumi

Kumada, Takashi
License Information

Text and Data Mining valid from 2026-02-05

Version of Record valid from 2026-02-05
More Information

Article History

Received: 8 January 2025

Accepted: 29 January 2026

First Online: 5 February 2026